Home › News and Press › Press releases › Page 2

News and Press releases

View all News Press releases

Oxcia AB Publishes Year-End Report for 2023

February 22, 2024 · Press releases

Key milestone for OXC-201 – patent approval in Japan

February 21, 2024 · Press releases

Oxcia AB (publ) publishes interim report fort the third quarter 2023

November 23, 2023 · Press releases

Oxcia AB presents positive effects of OXC-201 in lung tissue from patient with Idiopatic Pulmonary Fibrosis

October 23, 2023 · Press releases

Oxcia AB (publ) publishes interim report for the second quarter 2023

August 25, 2023 · Press releases

OXC-101 as a novel therapy for AML will be presented at 18[th] Annual Congress of International Drug Discovert Science & Technology, Amsterdam 12-14 July, 2023

August 23, 2023 · Press releases

OXC-101 as a novel therapy for AML will be presented at 18[th] Annual Congress of International Drug Discovery Science & Technology, Amsterdam 12-14 July, 2023

June 30, 2023 · Press releases

Oxcia AB (publ) publishes annual report

May 16, 2023 · Press releases

Oxcia AB (publ) publishes interim report fort the first quarter 2023

April 26, 2023 · Press releases

Oxcia has been awarded a grant of 3 million SEK for a study in refractory AML patients

April 3, 2023 · Press releases

Three abstracts on OXC-101 selected for poster presentations at AACR 2023

March 30, 2023 · Press releases

New pre-clinical study shows that OXC-201 may be a promising treatment for IPF (pulmonary fibrosis)

March 2, 2023 · Press releases

Search